SCHEMBL731383

SCHEMBL731383

CCOCCNC(=O)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.77
HPGD P15428 6/20 0.64
NPC1 O15118 5/20 0.63
RAB9A P51151 5/20 0.63
NAMPT P43490 1/20 0.59
NAAA Q02083 1/20 0.58
POLB P06746 2/20 0.57
LMNA P02545 1/20 0.57
NPSR1 Q6W5P4 1/20 0.56
PRSS1 P07477 1/20 0.56
CTSG P08311 1/20 0.56
CTRB1 P17538 1/20 0.56
CMA1 P23946 1/20 0.56
ALDH1A1 P00352 2/20 0.55
KMT2A Q03164 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
RECQL P46063 1/20 0.54
KDM4E B2RXH2 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11355224 0.94 SMN1; SMN2 (0.69) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL26646791 0.90 HPGD (0.73) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL25970084 0.89 SMN1; SMN2 (0.96) SMN1; SMN2HPGDNPC1RAB9ANAAA
SCHEMBL12445445 0.88 SMN1; SMN2 (0.81) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL15978900 0.88 SMN1; SMN2 (0.69) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL20734830 0.87 SMN1; SMN2 (1.00) SMN1; SMN2HPGDNPC1RAB9ANAAA
SCHEMBL16361209 0.87 SMN1; SMN2 (0.84) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL9348556 0.85 SMN1; SMN2 (0.76) SMN1; SMN2HPGDNPC1RAB9ANAMPT
SCHEMBL30910449 0.85 SMN1; SMN2 (0.87) SMN1; SMN2HPGDNPC1RAB9ANAAA
SCHEMBL12301884 0.85 NPC1 (0.67) SMN1; SMN2HPGDNPC1RAB9ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP claimed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US claimed
US-20240092790-A1 DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-03-21 US disclosed
CN-107033069-B Novel irreversible Bruton's tyrosine kinase inhibitor 中国科学院合肥物质科学研究院 2022-03-04 CN disclosed
CN-109053697-A A kind of pyrimidines and preparation method thereof for anticancer 张淑华 2018-12-21 CN disclosed
EP-1965255-B1 Color filter and method for making the color filter FUJIFILM CORP (JP) 2015-08-12 EP disclosed
EP-2629149-A2 Colored curable composition, color filter and manufacturing method thereof Fujifilm Corporation (JP) 2013-08-21 EP disclosed
US-8137890-B2 Colored photosensitive composition, color filter, and method for manufacturing color filter FUJIFILM CORPORATION (JP) 2012-03-20 US disclosed
EP-2028544-B1 Colored photosensitive composition, color filter, and method for manufacturing color filter FUJIFILM CORP (JP) 2011-10-12 EP disclosed
US-8029951-B2 Colored curable composition, color filter and production method thereof FUJIFILM CORPORATION (JP) 2011-10-04 US disclosed
US-7914956-B2 Dye-containing negative working curable composition, color filter and production method thereof FUJIFILM CORPORATION (JP) 2011-03-29 US disclosed
US-20080206660-A1 COLORED PHOTOSENSITIVE COMPOSITION, COLOR FILTER, AND METHOD FOR MAKING THE COLOR FILTER FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
US-20080081268-A1 COLORED CURABLE COMPOSITION, COLOR FILTER AND PRODUCTION METHOD THEREOF FUJIFILM CORPORATION (JP) 2008-04-03 US disclosed
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP disclosed
US-20070212623-A1 Dye-containing negative working curable composition, color filter and production method thereof FUJIFILM CORPORATION (JP) 2007-09-13 US disclosed
US-20070190435-A1 Dye-containing photosensitive composition, color filter using the same, and production method thereof FUJIFILM CORPORATION (JP) 2007-08-16 US disclosed
US-20070099096-A1 Dye-containing curable composition, color filter and method of producing thereof FUJIFILM CORPORATION 2007-05-03 US disclosed
EP-1780598-A1 COLORED CURABLE COMPOSITIONS, COLOR FILTERS AND PROCESS FOR PRODUCTION THEREOF FUJIFILM Corporation (JP) 2007-05-02 EP disclosed
US-20070072096-A1 Negative curable dye-containing composition, color filter, and method of manufacturing the same FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092790-A1 DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS ROCK1, ROCK2, RHOA SMN1; SMN2 4674/4885HPGD 61/4885NPC1 1946/4885
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents PYGL, GYS2, AGL SMN1; SMN2 4705/4885HPGD 3765/4885NPC1 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.